Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease.
AUTOR(ES)
de Bono, D.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1025439Documentos Relacionados
- Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
- Origins of the specificity of tissue-type plasminogen activator.
- Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
- Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells.
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator: Prospective Review